Literature DB >> 12762573

Particulate air pollution and hospital admissions for cardiorespiratory diseases: are the elderly at greater risk?

H R Anderson1, R W Atkinson, S A Bremner, L Marston.   

Abstract

A systematic literature review suggests that particulate air pollution is associated with daily admissions for both respiratory and cardiac diseases in people aged > 65 yrs. A model of acute effects is proposed which shows how admissions can be brought forward by a relatively short period of time as well as events being added that would not have happened at all except for air pollution. A model of the effects of air pollution on chronic disease is proposed that provides the background of long-term vulnerability upon which the increased short-term vulnerability is superimposed. A study of daily hospital admissions in London shows that for respiratory disease the relative risks of admission associated with particles reduce with increasing age, while for cardiac disease, there is no trend. When the attributable risk is estimated using baseline admission rates for respiratory disease, it is children who have the highest attributable risk, followed by the elderly. For cardiac disease there is a steep increase in attributable risk with age, reflecting the dominant influence of baseline risks. The attributable risk for cardiovascular disease in the elderly is considerably greater than for respiratory disease, due to higher baseline admission rates.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12762573     DOI: 10.1183/09031936.03.00402203

Source DB:  PubMed          Journal:  Eur Respir J Suppl        ISSN: 0904-1850


  33 in total

1.  Poor asthma control and exposure to traffic pollutants and obesity in older adults.

Authors:  Tolly G Epstein; Patrick H Ryan; Grace K LeMasters; Cheryl K Bernstein; Linda S Levin; Jonathan A Bernstein; Manuel S Villareal; David I Bernstein
Journal:  Ann Allergy Asthma Immunol       Date:  2012-05-01       Impact factor: 6.347

2.  Air pollution and mortality in São Paulo, Brazil: Effects of multiple pollutants and analysis of susceptible populations.

Authors:  Mercedes A Bravo; Jiyoung Son; Clarice Umbelino de Freitas; Nelson Gouveia; Michelle L Bell
Journal:  J Expo Sci Environ Epidemiol       Date:  2015-01-14       Impact factor: 5.563

3.  Occupational Lung Diseases among Soldiers Deployed to Iraq and Afghanistan.

Authors:  Anthony M Szema
Journal:  Occup Med Health Aff       Date:  2013

4.  Fine particulate matter air pollution and cognitive function among U.S. older adults.

Authors:  Jennifer A Ailshire; Philippa Clarke
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2014-06-06       Impact factor: 4.077

5.  Fine particulate matter air pollution and cognitive function among older US adults.

Authors:  Jennifer A Ailshire; Eileen M Crimmins
Journal:  Am J Epidemiol       Date:  2014-06-24       Impact factor: 4.897

6.  Forecasting daily attendances at an emergency department to aid resource planning.

Authors:  Yan Sun; Bee Hoon Heng; Yian Tay Seow; Eillyne Seow
Journal:  BMC Emerg Med       Date:  2009-01-29

7.  Spatial analysis of MODIS aerosol optical depth, PM2.5, and chronic coronary heart disease.

Authors:  Zhiyong Hu
Journal:  Int J Health Geogr       Date:  2009-05-12       Impact factor: 3.918

8.  The impact of new research technologies on our understanding of environmental causes of disease: the concept of clinical vulnerability.

Authors:  Paolo Vineis; Aneire E Khan; Jelle Vlaanderen; Roel Vermeulen
Journal:  Environ Health       Date:  2009-11-30       Impact factor: 5.984

9.  Particulate matter and atherosclerosis: role of particle size, composition and oxidative stress.

Authors:  Jesus A Araujo; Andre E Nel
Journal:  Part Fibre Toxicol       Date:  2009-09-18       Impact factor: 9.400

10.  Particulate air pollution and chronic ischemic heart disease in the eastern United States: a county level ecological study using satellite aerosol data.

Authors:  Zhiyong Hu; K Ranga Rao
Journal:  Environ Health       Date:  2009-06-12       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.